Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 2003

View Archived Issues

Abgenix and Chugai enter antibody therapeutics agreement

Daiichi selects compound from Pharmacopeia collaboration for preclinical development

GlycoDesign regains rights to Core 2 inhibitors

Sidmak Laboratories to change name to Pliva

New data on the anticancer efficacy of the nitrosourea derivative aranoza

Pfizer claims new 5-HT2C receptor modulators and their use in sexual disorders

Boehringer Ingelheim presents novel thrombin inhibitors

Ferring researchers identify new oxytocin agonists

New series of 5-HT6/5-HT7 ligands discovered at Sigma-Tau

Antibacterial agents discovered in joint research by Essential Therapeutics and Pliva

Novel antiherpesvirus agents in early development at GSK

Schering presents new VEGF inhibitors

New PDE5 inhibitors identified by Lilly Icos team

Research term extended in 3DP thrombin collaboration

IND cleared for NCX-1000

Japanese marketing approval sought for Glivec for GIST indication

AES-14 granted fast track status for oral mucositis associated with cancer chemotherapy

Japanese marketing application for E-7155 withdrawn

Baxter proposes Advate as brand name for rAHF-PFM

Revimid granted fast track designation for relapsed or refractory multiple myeloma

Phase III study initiated for HL-10 in ALI/ARDS

Myriad Genetics discovers DEP1 gene for depression

Cell Genesys refocuses resource investment

MS-325 phase III program completes enrollment

Nuvelo begins trading this week

Novel cytotoxic metabolite isolated from marine bacterium

MIT details the rational design of LMWHs with improved properties

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...